Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
letter
. 1993 Oct;110(Suppl):81P–184P. doi: 10.1111/j.1476-5381.1993.tb16292.x

POSTER COMMUNICATIONS

PMCID: PMC2175557  PMID: 19108271

Full text

PDF
81P

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abi-Dargham A., Laruelle M., Wong D. T., Robertson D. W., Weinberger D. R., Kleinman J. E. Pharmacological and regional characterization of [3H]LY278584 binding sites in human brain. J Neurochem. 1993 Feb;60(2):730–737. doi: 10.1111/j.1471-4159.1993.tb03208.x. [DOI] [PubMed] [Google Scholar]
  2. Altura B. M., Altura B. T., Carella A., Turlapaty P. D. Ca2+ coupling in vascular smooth muscle: Mg2+ and buffer effects on contractility and membrane Ca2+ movements. Can J Physiol Pharmacol. 1982 Apr;60(4):459–482. doi: 10.1139/y82-066. [DOI] [PubMed] [Google Scholar]
  3. Andersen P. H. The dopamine inhibitor GBR 12909: selectivity and molecular mechanism of action. Eur J Pharmacol. 1989 Aug 3;166(3):493–504. doi: 10.1016/0014-2999(89)90363-4. [DOI] [PubMed] [Google Scholar]
  4. Antin J., Gibbs J., Holt J., Young R. C., Smith G. P. Cholecystokinin elicits the complete behavioral sequence of satiety in rats. J Comp Physiol Psychol. 1975 Sep;89(7):784–790. doi: 10.1037/h0077040. [DOI] [PubMed] [Google Scholar]
  5. Arena J. P., Kass R. S. Block of heart potassium channels by clofilium and its tertiary analogs: relationship between drug structure and type of channel blocked. Mol Pharmacol. 1988 Jul;34(1):60–66. [PubMed] [Google Scholar]
  6. Auer R. N., Jensen M. L., Whishaw I. Q. Neurobehavioral deficit due to ischemic brain damage limited to half of the CA1 sector of the hippocampus. J Neurosci. 1989 May;9(5):1641–1647. doi: 10.1523/JNEUROSCI.09-05-01641.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bagdy D., Barabás E., Szabó G., Bajusz S., Széll E. In vivo anticoagulant and antiplatelet effect of D-Phe-Pro-Arg-H and D-MePhe-Pro-Arg-H. Thromb Haemost. 1992 Mar 2;67(3):357–365. [PubMed] [Google Scholar]
  8. Bailey S. J., Hickman D., Hourani S. M. Characterization of the P1-purinoceptors mediating contraction of the rat colon muscularis mucosae. Br J Pharmacol. 1992 Feb;105(2):400–404. doi: 10.1111/j.1476-5381.1992.tb14265.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Baird A. W., Margolius H. S. Bradykinin stimulates electrogenic bicarbonate secretion by the guinea pig gallbladder. J Pharmacol Exp Ther. 1989 Jan;248(1):268–272. [PubMed] [Google Scholar]
  10. Barnes J. M., Barnes N. M., Costall B., Horovitz Z. P., Naylor R. J. Angiotensin II inhibits the release of [3H]acetylcholine from rat entorhinal cortex in vitro. Brain Res. 1989 Jul 3;491(1):136–143. doi: 10.1016/0006-8993(89)90095-4. [DOI] [PubMed] [Google Scholar]
  11. Barnes J. M., Barnes N. M., Costall B., Ironside J. W., Naylor R. J. Identification and characterisation of 5-hydroxytryptamine 3 recognition sites in human brain tissue. J Neurochem. 1989 Dec;53(6):1787–1793. doi: 10.1111/j.1471-4159.1989.tb09244.x. [DOI] [PubMed] [Google Scholar]
  12. Barnes N. M., Cheng C. H., Costall B., Ge J., Naylor R. J. Differential modulation of extracellular levels of 5-hydroxytryptamine in the rat frontal cortex by (R)- and (S)-zacopride. Br J Pharmacol. 1992 Sep;107(1):233–239. doi: 10.1111/j.1476-5381.1992.tb14492.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Beal M. F., Kowall N. W., Ellison D. W., Mazurek M. F., Swartz K. J., Martin J. B. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature. 1986 May 8;321(6066):168–171. doi: 10.1038/321168a0. [DOI] [PubMed] [Google Scholar]
  14. Bean B. P. Neurotransmitter inhibition of neuronal calcium currents by changes in channel voltage dependence. Nature. 1989 Jul 13;340(6229):153–156. doi: 10.1038/340153a0. [DOI] [PubMed] [Google Scholar]
  15. Belardinelli L., Fenton R. A., West A., Linden J., Althaus J. S., Berne R. M. Extracellular action of adenosine and the antagonism by aminophylline on the atrioventricular conduction of isolated perfused guinea pig and rat hearts. Circ Res. 1982 Nov;51(5):569–579. doi: 10.1161/01.res.51.5.569. [DOI] [PubMed] [Google Scholar]
  16. Belardinelli L., Isenberg G. Isolated atrial myocytes: adenosine and acetylcholine increase potassium conductance. Am J Physiol. 1983 May;244(5):H734–H737. doi: 10.1152/ajpheart.1983.244.5.H734. [DOI] [PubMed] [Google Scholar]
  17. Belzung C., Misslin R., Vogel E. Behavioural effects of the benzodiazepine receptor partial agonist RO 16-6028 in mice. Psychopharmacology (Berl) 1989;97(3):388–391. doi: 10.1007/BF00439456. [DOI] [PubMed] [Google Scholar]
  18. Bennett G. W., Marsden C. A., Fone K. C., Johnson J. V., Heal D. J. TRH-catecholamine interactions in brain and spinal cord. Ann N Y Acad Sci. 1989;553:106–120. [PubMed] [Google Scholar]
  19. Benveniste H. The excitotoxin hypothesis in relation to cerebral ischemia. Cerebrovasc Brain Metab Rev. 1991 Fall;3(3):213–245. [PubMed] [Google Scholar]
  20. Bill D. J., Knight M., Forster E. A., Fletcher A. Direct evidence for an important species difference in the mechanism of 8-OH-DPAT-induced hypothermia. Br J Pharmacol. 1991 Aug;103(4):1857–1864. doi: 10.1111/j.1476-5381.1991.tb12342.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Björck T., Dahlén S. E. Leukotrienes and histamine mediate IgE-dependent contractions of human bronchi: pharmacological evidence obtained with tissues from asthmatic and non-asthmatic subjects. Pulm Pharmacol. 1993 Mar;6(1):87–96. doi: 10.1006/pulp.1993.1012. [DOI] [PubMed] [Google Scholar]
  22. Blundell J. E. Is there a role for serotonin (5-hydroxytryptamine) in feeding? Int J Obes. 1977;1(1):15–42. [PubMed] [Google Scholar]
  23. Bolton T. B., Clapp L. H. The diverse effects of noradrenaline and other stimulants on 86Rb and 42K efflux in rabbit and guinea-pig arterial muscle. J Physiol. 1984 Oct;355:43–63. doi: 10.1113/jphysiol.1984.sp015405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Bolton T. B. Mechanisms of action of transmitters and other substances on smooth muscle. Physiol Rev. 1979 Jul;59(3):606–718. doi: 10.1152/physrev.1979.59.3.606. [DOI] [PubMed] [Google Scholar]
  25. Brading A. F., Sneddon P. Evidence for multiple sources of calcium for activation of the contractile mechanism of guinea-pig taenia coli on stimulation with carbachol. Br J Pharmacol. 1980 Oct;70(2):229–240. doi: 10.1111/j.1476-5381.1980.tb07928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Brayden D. J., Hanley M. R., Thastrup O., Cuthbert A. W. Thapsigargin, a new calcium-dependent epithelial anion secretagogue. Br J Pharmacol. 1989 Nov;98(3):809–816. doi: 10.1111/j.1476-5381.1989.tb14609.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Bredt D. S., Hwang P. M., Snyder S. H. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature. 1990 Oct 25;347(6295):768–770. doi: 10.1038/347768a0. [DOI] [PubMed] [Google Scholar]
  28. Buchheit K. H., Gamse R., Pfannkuche H. J. SDZ 205-557, a selective antagonist at 5-HT4 receptors in the isolated guinea pig ileum. Eur J Pharmacol. 1991 Aug 6;200(2-3):373–374. doi: 10.1016/0014-2999(91)90601-l. [DOI] [PubMed] [Google Scholar]
  29. Buchheit K. H., Gamse R., Pfannkuche H. J. SDZ 205-557, a selective antagonist at 5-HT4 receptors in the isolated guinea pig ileum. Eur J Pharmacol. 1991 Aug 6;200(2-3):373–374. doi: 10.1016/0014-2999(91)90601-l. [DOI] [PubMed] [Google Scholar]
  30. Burnstock G., Kennedy C. Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol. 1985;16(5):433–440. doi: 10.1016/0306-3623(85)90001-1. [DOI] [PubMed] [Google Scholar]
  31. Buxton I. L., Cheek D. J., Eckman D., Westfall D. P., Sanders K. M., Keef K. D. NG-nitro L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ Res. 1993 Feb;72(2):387–395. doi: 10.1161/01.res.72.2.387. [DOI] [PubMed] [Google Scholar]
  32. Böhm M., Meyer W., Mügge A., Schmitz W., Scholz H. Functional evidence for the existence of adenosine receptors in the human heart. Eur J Pharmacol. 1985 Oct 22;116(3):323–326. doi: 10.1016/0014-2999(85)90170-0. [DOI] [PubMed] [Google Scholar]
  33. Böhm M., Pieske B., Ungerer M., Erdmann E. Characterization of A1 adenosine receptors in atrial and ventricular myocardium from diseased human hearts. Circ Res. 1989 Nov;65(5):1201–1211. doi: 10.1161/01.res.65.5.1201. [DOI] [PubMed] [Google Scholar]
  34. Castle N. A. Selective inhibition of potassium currents in rat ventricle by clofilium and its tertiary homolog. J Pharmacol Exp Ther. 1991 Apr;257(1):342–350. [PubMed] [Google Scholar]
  35. Cerbai E., Klöckner U., Isenberg G. Ca-antagonistic effects of adenosine in guinea pig atrial cells. Am J Physiol. 1988 Oct;255(4 Pt 2):H872–H878. doi: 10.1152/ajpheart.1988.255.4.H872. [DOI] [PubMed] [Google Scholar]
  36. Challiss R. A., Patel N., Adams D., Arch J. R. Inhibitory action of the potassium channel opener BRL 38227 on agonist-stimulated phosphoinositide metabolism in bovine tracheal smooth muscle. Biochem Pharmacol. 1992 Jan 9;43(1):17–20. doi: 10.1016/0006-2952(92)90655-3. [DOI] [PubMed] [Google Scholar]
  37. Cho H. L., Ho P. P., Mihelich E. D., Snyder D. W. Relative potencies of 5-lipoxygenase inhibitors on antigen-induced contractions of guinea pig tracheal strips. J Pharmacol Methods. 1991 Dec;26(4):277–287. doi: 10.1016/0160-5402(91)90038-7. [DOI] [PubMed] [Google Scholar]
  38. Cliff W. H., Frizzell R. A. Separate Cl- conductances activated by cAMP and Ca2+ in Cl(-)-secreting epithelial cells. Proc Natl Acad Sci U S A. 1990 Jul;87(13):4956–4960. doi: 10.1073/pnas.87.13.4956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Cockle S. M., Aitken A., Beg F., Morrell J. M., Smyth D. G. The TRH-related peptide pyroglutamyglutamylprolinamide is present in human semen. FEBS Lett. 1989 Jul 31;252(1-2):113–117. doi: 10.1016/0014-5793(89)80900-7. [DOI] [PubMed] [Google Scholar]
  40. Cockle S. M., Aitken A., Beg F., Smyth D. G. A novel peptide, pyroglutamylglutamylproline amide, in the rabbit prostate complex, structurally related to thyrotrophin-releasing hormone. J Biol Chem. 1989 May 15;264(14):7788–7791. [PubMed] [Google Scholar]
  41. Coldwell M. C., Bowen W. P., Brown F., Browne M. J., Fears R., Hadley M. S., Hicks F. R., Mannix C. J., Riley G. J. Evidence for more than one binding site in cloned D2 and D3 dopamine receptors. Biochem Soc Trans. 1993 Feb;21(1):56S–56S. doi: 10.1042/bst021056s. [DOI] [PubMed] [Google Scholar]
  42. Coleman D. J., Foo I. T., Sharpe D. T. Textured or smooth implants for breast augmentation? A prospective controlled trial. Br J Plast Surg. 1991 Aug-Sep;44(6):444–448. doi: 10.1016/0007-1226(91)90204-w. [DOI] [PubMed] [Google Scholar]
  43. Collis M. G. Evidence for an A1-adenosine receptor in the guinea-pig atrium. Br J Pharmacol. 1983 Jan;78(1):207–212. doi: 10.1111/j.1476-5381.1983.tb09381.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Collis M. G. Evidence for an A1-adenosine receptor in the guinea-pig atrium. Br J Pharmacol. 1983 Jan;78(1):207–212. doi: 10.1111/j.1476-5381.1983.tb09381.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Collis M. G., Jacobson K. A., Tomkins D. M. Apparent affinity of some 8-phenyl-substituted xanthines at adenosine receptors in guinea-pig aorta and atria. Br J Pharmacol. 1987 Sep;92(1):69–75. doi: 10.1111/j.1476-5381.1987.tb11297.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Connor H. E., Feniuk W., Humphrey P. P., Perren M. J. 5-Carboxamidotryptamine is a selective agonist at 5-hydroxytryptamine receptors mediating vasodilatation and tachycardia in anaesthetized cats. Br J Pharmacol. 1986 Feb;87(2):417–426. doi: 10.1111/j.1476-5381.1986.tb10832.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Corin W. J., Monrad E. S., Strom J. A., Giustino S., Sonnenblick E. S., LeJemtel T. Flosequinan: a vasodilator with positive inotropic activity. Am Heart J. 1991 Feb;121(2 Pt 1):537–540. doi: 10.1016/0002-8703(91)90723-u. [DOI] [PubMed] [Google Scholar]
  48. Cornblath D. R., McArthur J. C., Kennedy P. G., Witte A. S., Griffin J. W. Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Ann Neurol. 1987 Jan;21(1):32–40. doi: 10.1002/ana.410210107. [DOI] [PubMed] [Google Scholar]
  49. Costall B., Jones B. J., Kelly M. E., Naylor R. J., Tomkins D. M. Exploration of mice in a black and white test box: validation as a model of anxiety. Pharmacol Biochem Behav. 1989 Mar;32(3):777–785. doi: 10.1016/0091-3057(89)90033-6. [DOI] [PubMed] [Google Scholar]
  50. Crick H., Wallis D. I. Inhibition of reflex responses of neonate rat lumbar spinal cord by 5-hydroxytryptamine. Br J Pharmacol. 1991 Jul;103(3):1769–1775. doi: 10.1111/j.1476-5381.1991.tb09861.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Curtis M. J., Hearse D. J. Ischaemia-induced and reperfusion-induced arrhythmias differ in their sensitivity to potassium: implications for mechanisms of initiation and maintenance of ventricular fibrillation. J Mol Cell Cardiol. 1989 Jan;21(1):21–40. doi: 10.1016/0022-2828(89)91490-9. [DOI] [PubMed] [Google Scholar]
  52. Curtis M. J., Hearse D. J. Reperfusion-induced arrhythmias are critically dependent upon occluded zone size: relevance to the mechanism of arrhythmogenesis. J Mol Cell Cardiol. 1989 Jun;21(6):625–637. doi: 10.1016/0022-2828(89)90828-6. [DOI] [PubMed] [Google Scholar]
  53. Cutler M. G. An ethological study of the effects of buspirone and the 5-HT3 receptor antagonist, BRL 43694 (granisetron) on behaviour during social interactions in female and male mice. Neuropharmacology. 1991 Apr;30(4):299–306. doi: 10.1016/0028-3908(91)90053-e. [DOI] [PubMed] [Google Scholar]
  54. DAVIDSON J., SJOERDSMA A., LOOMIS L. N., UDENFRIEND S. Studies with the serotonin precursor, 5-hydroxytryptophan, in experimental animals and man. J Clin Invest. 1957 Nov;36(11):1594–1599. doi: 10.1172/JCI103558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Dai S. Effects of ranitidine and cimetidine on experimentally induced ventricular arrhythmias in anaesthetized rats. Agents Actions. 1986 Mar;17(5-6):460–465. doi: 10.1007/BF01965514. [DOI] [PubMed] [Google Scholar]
  56. Dolin S. J., Halsey M. J., Little H. J. Effects of the calcium channel activator Bay K 8644 on general anaesthetic potency in mice. Br J Pharmacol. 1988 Jun;94(2):413–422. doi: 10.1111/j.1476-5381.1988.tb11543.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Dolin S. J., Little H. J. Are changes in neuronal calcium channels involved in ethanol tolerance? J Pharmacol Exp Ther. 1989 Sep;250(3):985–991. [PubMed] [Google Scholar]
  58. Dolin S., Little H., Hudspith M., Pagonis C., Littleton J. Increased dihydropyridine-sensitive calcium channels in rat brain may underlie ethanol physical dependence. Neuropharmacology. 1987 Feb-Mar;26(2-3):275–279. doi: 10.1016/0028-3908(87)90220-6. [DOI] [PubMed] [Google Scholar]
  59. Dressler K. A., Kolesnick R. N. Ceramide 1-phosphate, a novel phospholipid in human leukemia (HL-60) cells. Synthesis via ceramide from sphingomyelin. J Biol Chem. 1990 Sep 5;265(25):14917–14921. [PubMed] [Google Scholar]
  60. Dumuis A., Bouhelal R., Sebben M., Bockaert J. A 5-HT receptor in the central nervous system, positively coupled with adenylate cyclase, is antagonized by ICS 205 930. Eur J Pharmacol. 1988 Jan 27;146(1):187–188. doi: 10.1016/0014-2999(88)90503-1. [DOI] [PubMed] [Google Scholar]
  61. Durand D., Carlen P. L. Impairment of long-term potentiation in rat hippocampus following chronic ethanol treatment. Brain Res. 1984 Aug 13;308(2):325–332. doi: 10.1016/0006-8993(84)91072-2. [DOI] [PubMed] [Google Scholar]
  62. Ebenezer I. S. Effects of the 5HT1A agonist, 8-OH-DPAT, on operant food intake in non-deprived rats. Neuroreport. 1992 Jan;3(1):62–64. doi: 10.1097/00001756-199201000-00016. [DOI] [PubMed] [Google Scholar]
  63. Edbury S. M., Hemmings F. J., Davie R. J., Birch N. J. Comparison of inhibitory effects of lithium and magnesium on longitudinal smooth muscle contraction. Biochem Soc Trans. 1991 Nov;19(4):411S–411S. doi: 10.1042/bst019411s. [DOI] [PubMed] [Google Scholar]
  64. Eden R. J., Costall B., Domeney A. M., Gerrard P. A., Harvey C. A., Kelly M. E., Naylor R. J., Owen D. A., Wright A. Preclinical pharmacology of ropinirole (SK&F 101468-A) a novel dopamine D2 agonist. Pharmacol Biochem Behav. 1991 Jan;38(1):147–154. doi: 10.1016/0091-3057(91)90603-y. [DOI] [PubMed] [Google Scholar]
  65. Eglen R. M., Alvarez R., Johnson L. G., Leung E., Wong E. H. The action of SDZ 205,557 at 5-hydroxytryptamine (5-HT3 and 5-HT4) receptors. Br J Pharmacol. 1993 Feb;108(2):376–382. doi: 10.1111/j.1476-5381.1993.tb12812.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Eglen R. M., Alvarez R., Johnson L. G., Leung E., Wong E. H. The action of SDZ 205,557 at 5-hydroxytryptamine (5-HT3 and 5-HT4) receptors. Br J Pharmacol. 1993 Feb;108(2):376–382. doi: 10.1111/j.1476-5381.1993.tb12812.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Fernstrom M. H., Massoudi M. S., Fernstrom J. D. Effect of 8-hydroxy-2-(di-n-propylamino)-tetralin on the tryptophan-induced increase in 5-hydroxytryptophan accumulation in rat brain. Life Sci. 1990;47(4):283–289. doi: 10.1016/0024-3205(90)90585-f. [DOI] [PubMed] [Google Scholar]
  68. Finegan B. A., Clanachan A. S. Comparison of the haemodynamic effects of adenosine monophosphate with sodium nitroprusside in a canine model of acute global left ventricular dysfunction. Br J Pharmacol. 1991 Jul;103(3):1691–1696. doi: 10.1111/j.1476-5381.1991.tb09848.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Fischer E., Marano M. A., Van Zee K. J., Rock C. S., Hawes A. S., Thompson W. A., DeForge L., Kenney J. S., Remick D. G., Bloedow D. C. Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia. J Clin Invest. 1992 May;89(5):1551–1557. doi: 10.1172/JCI115748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Fox W. W., Duara S. Persistent pulmonary hypertension in the neonate: diagnosis and management. J Pediatr. 1983 Oct;103(4):505–514. doi: 10.1016/s0022-3476(83)80573-3. [DOI] [PubMed] [Google Scholar]
  71. Frenken M., Kaumann A. J. Interaction of ketanserin and its metabolite ketanserinol with 5HT2 receptors in pulmonary and coronary arteries of calf. Naunyn Schmiedebergs Arch Pharmacol. 1984 Jul;326(4):334–339. doi: 10.1007/BF00501438. [DOI] [PubMed] [Google Scholar]
  72. Förster W. Prostaglandins and prostaglandin precursors as endogenous antiarrhythmic principles of the heart. Acta Biol Med Ger. 1976;35(8-9):1101–1112. [PubMed] [Google Scholar]
  73. Gardner M. L., Samson R. R., Heading R. C. Changes in absorptive and peptide hydrolase activities in rat small intestine after administration of 5-fluorouracil. Clin Sci Mol Med. 1978 Apr;54(4):411–418. doi: 10.1042/cs0540411. [DOI] [PubMed] [Google Scholar]
  74. Garland C. J., McPherson G. A. Evidence that nitric oxide does not mediate the hyperpolarization and relaxation to acetylcholine in the rat small mesenteric artery. Br J Pharmacol. 1992 Feb;105(2):429–435. doi: 10.1111/j.1476-5381.1992.tb14270.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Garret C., Carruette A., Fardin V., Moussaoui S., Peyronel J. F., Blanchard J. C., Laduron P. M. Pharmacological properties of a potent and selective nonpeptide substance P antagonist. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10208–10212. doi: 10.1073/pnas.88.22.10208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Gerencer R. Z., Finegan B. A., Clanachan A. S. Cardiovascular selectivity of adenosine receptor agonists in anaesthetized dogs. Br J Pharmacol. 1992 Dec;107(4):1048–1056. doi: 10.1111/j.1476-5381.1992.tb13405.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Gibson A., Mirzazadeh S., Hobbs A. J., Moore P. K. L-NG-monomethyl arginine and L-NG-nitro arginine inhibit non-adrenergic, non-cholinergic relaxation of the mouse anococcygeus muscle. Br J Pharmacol. 1990 Mar;99(3):602–606. doi: 10.1111/j.1476-5381.1990.tb12976.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Giembycz M. A., Raeburn D. Putative substrates for cyclic nucleotide-dependent protein kinases and the control of airway smooth muscle tone. J Auton Pharmacol. 1991 Dec;11(6):365–398. doi: 10.1111/j.1474-8673.1991.tb00260.x. [DOI] [PubMed] [Google Scholar]
  79. Gille E., Lemoine H., Ehle B., Kaumann A. J. The affinity of (-)-propranolol for beta 1- and beta 2-adrenoceptors of human heart. Differential antagonism of the positive inotropic effects and adenylate cyclase stimulation by (-)-noradrenaline and (-)-adrenaline. Naunyn Schmiedebergs Arch Pharmacol. 1985 Oct;331(1):60–70. doi: 10.1007/BF00498852. [DOI] [PubMed] [Google Scholar]
  80. Gillespie J. S. The rat anococcygeus muscle and its response to nerve stimulation and to some drugs. Br J Pharmacol. 1972 Jul;45(3):404–416. doi: 10.1111/j.1476-5381.1972.tb08097.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Girerd X. J., Hirsch A. T., Cooke J. P., Dzau V. J., Creager M. A. L-arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits. Circ Res. 1990 Dec;67(6):1301–1308. doi: 10.1161/01.res.67.6.1301. [DOI] [PubMed] [Google Scholar]
  82. Grossman C. J., Kilpatrick G. J., Bunce K. T. Development of a radioligand binding assay for 5-HT4 receptors in guinea-pig and rat brain. Br J Pharmacol. 1993 Jul;109(3):618–624. doi: 10.1111/j.1476-5381.1993.tb13617.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Gurden M. F., Coates J., Ellis F., Evans B., Foster M., Hornby E., Kennedy I., Martin D. P., Strong P., Vardey C. J. Functional characterization of three adenosine receptor types. Br J Pharmacol. 1993 Jul;109(3):693–698. doi: 10.1111/j.1476-5381.1993.tb13629.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Gustafsson L. E. Adenosine antagonism and related effects of theophylline derivatives in guinea pig ileum longitudinal muscle. Acta Physiol Scand. 1984 Oct;122(2):191–198. doi: 10.1111/j.1748-1716.1984.tb07498.x. [DOI] [PubMed] [Google Scholar]
  85. Hamon M., Bourgoin S., Glowinski J. Feedback regulation of 5-HT synthesis in rat striatal slices. J Neurochem. 1973 Jun;20(6):1727–1745. doi: 10.1111/j.1471-4159.1973.tb00288.x. [DOI] [PubMed] [Google Scholar]
  86. Hansen A. J., Hounsgaard J., Jahnsen H. Anoxia increases potassium conductance in hippocampal nerve cells. Acta Physiol Scand. 1982 Jul;115(3):301–310. doi: 10.1111/j.1748-1716.1982.tb07082.x. [DOI] [PubMed] [Google Scholar]
  87. Harden T. K. Agonist-induced desensitization of the beta-adrenergic receptor-linked adenylate cyclase. Pharmacol Rev. 1983 Mar;35(1):5–32. [PubMed] [Google Scholar]
  88. Heyman S. N., Clark B. A., Kaiser N., Spokes K., Rosen S., Brezis M., Epstein F. H. Radiocontrast agents induce endothelin release in vivo and in vitro. J Am Soc Nephrol. 1992 Jul;3(1):58–65. doi: 10.1681/ASN.V3158. [DOI] [PubMed] [Google Scholar]
  89. Heyman S. N., Rosen S., Silva P., Spokes K., Egorin M. J., Epstein F. H. Protective action of glycine in cisplatin nephrotoxicity. Kidney Int. 1991 Aug;40(2):273–279. doi: 10.1038/ki.1991.210. [DOI] [PubMed] [Google Scholar]
  90. Hirata Y., Yoshimi H., Takata S., Watanabe T. X., Kumagai S., Nakajima K., Sakakibara S. Cellular mechanism of action by a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells. Biochem Biophys Res Commun. 1988 Aug 15;154(3):868–875. doi: 10.1016/0006-291x(88)90220-3. [DOI] [PubMed] [Google Scholar]
  91. Hirsch C. F., Ensign J. C. Nutritionally defined conditions for germination of Streptomyces viridochromogenes spores. J Bacteriol. 1976 Apr;126(1):13–23. doi: 10.1128/jb.126.1.13-23.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Hoehn K., White T. D. N-methyl-D-aspartate, kainate and quisqualate release endogenous adenosine from rat cortical slices. Neuroscience. 1990;39(2):441–450. doi: 10.1016/0306-4522(90)90280-h. [DOI] [PubMed] [Google Scholar]
  93. Homer-Vanniasinkam S., Hardy S. C., Gough M. J. Reversal of the post-ischaemic changes in skeletal muscle blood flow and viability by a novel inhibitor of lipid peroxidation. Eur J Vasc Surg. 1993 Jan;7(1):41–45. doi: 10.1016/s0950-821x(05)80542-0. [DOI] [PubMed] [Google Scholar]
  94. Honda K., Takenaka T., Miyata-Osawa A., Terai M., Shiono K. Studies on YM-12617: a selective and potent antagonist of postsynaptic alpha 1-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol. 1985 Jan;328(3):264–272. doi: 10.1007/BF00515552. [DOI] [PubMed] [Google Scholar]
  95. Hope B. T., Michael G. J., Knigge K. M., Vincent S. R. Neuronal NADPH diaphorase is a nitric oxide synthase. Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2811–2814. doi: 10.1073/pnas.88.7.2811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Horne A. L., Harrison N. L., Turner J. P., Simmonds M. A. Spontaneous paroxysmal activity induced by zero magnesium and bicuculline: suppression by NMDA antagonists and GABA mimetics. Eur J Pharmacol. 1986 Mar 18;122(2):231–238. doi: 10.1016/0014-2999(86)90107-x. [DOI] [PubMed] [Google Scholar]
  97. Hoyer D., Waeber C., Schoeffter P., Palacios J. M., Dravid A. 5-HT1C receptor-mediated stimulation of inositol phosphate production in pig choroid plexus. A pharmacological characterization. Naunyn Schmiedebergs Arch Pharmacol. 1989 Mar;339(3):252–258. doi: 10.1007/BF00173573. [DOI] [PubMed] [Google Scholar]
  98. Humphrey P. P., Feniuk W., Perren M. J., Connor H. E., Oxford A. W., Coates L. H., Butina D. GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein. Br J Pharmacol. 1988 Aug;94(4):1123–1132. doi: 10.1111/j.1476-5381.1988.tb11630.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Hutcheson I. R., Whittle B. J., Boughton-Smith N. K. Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat. Br J Pharmacol. 1990 Dec;101(4):815–820. doi: 10.1111/j.1476-5381.1990.tb14163.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Ihara M., Noguchi K., Saeki T., Fukuroda T., Tsuchida S., Kimura S., Fukami T., Ishikawa K., Nishikibe M., Yano M. Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci. 1992;50(4):247–255. doi: 10.1016/0024-3205(92)90331-i. [DOI] [PubMed] [Google Scholar]
  101. Ihara M., Noguchi K., Saeki T., Fukuroda T., Tsuchida S., Kimura S., Fukami T., Ishikawa K., Nishikibe M., Yano M. Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci. 1992;50(4):247–255. doi: 10.1016/0024-3205(92)90331-i. [DOI] [PubMed] [Google Scholar]
  102. Isenberg G., Klockner U. Calcium tolerant ventricular myocytes prepared by preincubation in a "KB medium". Pflugers Arch. 1982 Oct;395(1):6–18. doi: 10.1007/BF00584963. [DOI] [PubMed] [Google Scholar]
  103. Ishihata A., Katano Y., Morinobu S., Endoh M. Influence of aging on the contractile response to endothelin of rat thoracic aorta. Eur J Pharmacol. 1991 Jul 23;200(1):199–201. doi: 10.1016/0014-2999(91)90689-n. [DOI] [PubMed] [Google Scholar]
  104. Jabbar S. A., Twentyman P. R., Watson J. V. The MTT assay underestimates the growth inhibitory effects of interferons. Br J Cancer. 1989 Oct;60(4):523–528. doi: 10.1038/bjc.1989.306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Jacobs M., Plane F., Bruckdorfer K. R. Native and oxidized low-density lipoproteins have different inhibitory effects on endothelium-derived relaxing factor in the rabbit aorta. Br J Pharmacol. 1990 May;100(1):21–26. doi: 10.1111/j.1476-5381.1990.tb12045.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Jansen I., Mortensen A., Edvinsson L. Characterization of calcitonin gene-related peptide receptors in human cerebral vessels. Vasomotor responses and cAMP accumulation. Ann N Y Acad Sci. 1992 Jun 30;657:435–440. doi: 10.1111/j.1749-6632.1992.tb22793.x. [DOI] [PubMed] [Google Scholar]
  107. Julou-Schaeffer G., Gray G. A., Fleming I., Schott C., Parratt J. R., Stoclet J. C. Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am J Physiol. 1990 Oct;259(4 Pt 2):H1038–H1043. doi: 10.1152/ajpheart.1990.259.4.H1038. [DOI] [PubMed] [Google Scholar]
  108. Kapanci Y., Assimacopoulos A., Irle C., Zwahlen A., Gabbiani G. "Contractile interstitial cells" in pulmonary alveolar septa: a possible regulator of ventilation-perfusion ratio? Ultrastructural, immunofluorescence, and in vitro studies. J Cell Biol. 1974 Feb;60(2):375–392. doi: 10.1083/jcb.60.2.375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Katsuki S., Murad F. Regulation of adenosine cyclic 3',5'-monophosphate and guanosine cyclic 3',5'-monophosphate levels and contractility in bovine tracheal smooth muscle. Mol Pharmacol. 1977 Mar;13(2):330–341. [PubMed] [Google Scholar]
  110. Kelly E., Keen M., Nobbs P., MacDermot J. Segregation of discrete GS alpha-mediated responses that accompany homologous or heterologous desensitization in two related somatic hybrids. Br J Pharmacol. 1990 Feb;99(2):309–316. doi: 10.1111/j.1476-5381.1990.tb14700.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Knabb R. M., Kettner C. A., Timmermans P. B., Reilly T. M. In vivo characterization of a new synthetic thrombin inhibitor. Thromb Haemost. 1992 Jan 23;67(1):56–59. [PubMed] [Google Scholar]
  112. Kubes P., Granger D. N. Nitric oxide modulates microvascular permeability. Am J Physiol. 1992 Feb;262(2 Pt 2):H611–H615. doi: 10.1152/ajpheart.1992.262.2.H611. [DOI] [PubMed] [Google Scholar]
  113. Leff P. An analysis of amplifying and potentiating interactions between agonists. J Pharmacol Exp Ther. 1987 Dec;243(3):1035–1042. [PubMed] [Google Scholar]
  114. Leff P., Martin G. R., Morse J. M. Differential classification of vascular smooth muscle and endothelial cell 5-HT receptors by use of tryptamine analogues. Br J Pharmacol. 1987 Jun;91(2):321–331. doi: 10.1111/j.1476-5381.1987.tb10287.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Lembeck F., Skofitsch G. Visceral pain reflex after pretreatment with capsaicin and morphine. Naunyn Schmiedebergs Arch Pharmacol. 1982 Nov;321(2):116–122. doi: 10.1007/BF00518478. [DOI] [PubMed] [Google Scholar]
  116. Liu S. F., Hislop A. A., Haworth S. G., Barnes P. J. Developmental changes in endothelium-dependent pulmonary vasodilatation in pigs. Br J Pharmacol. 1992 Jun;106(2):324–330. doi: 10.1111/j.1476-5381.1992.tb14335.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Loadman P. M., Bibby M. C., Double J. A., McElhinney R. S. Pharmacokinetics and cytotoxicity of B.3839, a molecular combination of 5-fluorouracil and N-(2-chloroethyl)-N-nitrosourea, in a mouse model. Invest New Drugs. 1992 Aug;10(3):149–158. doi: 10.1007/BF00877239. [DOI] [PubMed] [Google Scholar]
  118. Lomasney J. W., Cotecchia S., Lefkowitz R. J., Caron M. G. Molecular biology of alpha-adrenergic receptors: implications for receptor classification and for structure-function relationships. Biochim Biophys Acta. 1991 Oct 26;1095(2):127–139. doi: 10.1016/0167-4889(91)90075-9. [DOI] [PubMed] [Google Scholar]
  119. MacGregor D. G., Stone T. W. Inhibition by the adenosine analogue, (R-)-N6-phenylisopropyladenosine, of kainic acid neurotoxicity in rat hippocampus after systemic administration. Br J Pharmacol. 1993 Jun;109(2):316–321. doi: 10.1111/j.1476-5381.1993.tb13572.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. MacLean M. R., McGrath J. C. Effects of pre-contraction with endothelin-1 on alpha 2-adrenoceptor- and (endothelium-dependent) neuropeptide Y-mediated contractions in the isolated vascular bed of the rat tail. Br J Pharmacol. 1990 Sep;101(1):205–211. doi: 10.1111/j.1476-5381.1990.tb12114.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. Marcoux F. W., Goodrich J. E., Dominick M. A. Ketamine prevents ischemic neuronal injury. Brain Res. 1988 Jun 14;452(1-2):329–335. doi: 10.1016/0006-8993(88)90037-6. [DOI] [PubMed] [Google Scholar]
  122. Martin J. R., Pieri L., Bonetti E. P., Schaffner R., Burkard W. P., Cumin R., Haefely W. E. Ro 16-6028: a novel anxiolytic acting as a partial agonist at the benzodiazepine receptor. Pharmacopsychiatry. 1988 Nov;21(6):360–362. doi: 10.1055/s-2007-1021947. [DOI] [PubMed] [Google Scholar]
  123. Martinson E. A., Johnson R. A., Wells J. N. Potent adenosine receptor antagonists that are selective for the A1 receptor subtype. Mol Pharmacol. 1987 Mar;31(3):247–252. [PubMed] [Google Scholar]
  124. McElhinney R. S., McCormick J. E., Lucey C. M. Evolution of molecular combinations involving 5-fluorouracil. Cancer Treat Rev. 1988 Mar;15(1):73–81. doi: 10.1016/0305-7372(88)90012-6. [DOI] [PubMed] [Google Scholar]
  125. McGuirk J., Muscat R., Willner P. Effects of chronically administered fluoxetine and fenfluramine on food intake, body weight and the behavioural satiety sequence. Psychopharmacology (Berl) 1992;106(3):401–407. doi: 10.1007/BF02245426. [DOI] [PubMed] [Google Scholar]
  126. Meyer F. B., Anderson R. E., Sundt T. M., Jr, Yaksh T. L., Sharbrough F. W. Suppression of pentylenetetrazole seizures by oral administration of a dihydropyridine Ca2+ antagonist. Epilepsia. 1987 Jul-Aug;28(4):409–414. doi: 10.1111/j.1528-1157.1987.tb03666.x. [DOI] [PubMed] [Google Scholar]
  127. Millan M. J., Bervoets K., Colpaert F. C. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity. J Pharmacol Exp Ther. 1991 Mar;256(3):973–982. [PubMed] [Google Scholar]
  128. Mitchell J. A., Sheng H., Förstermann U., Murad F. Characterization of nitric oxide synthases in non-adrenergic non-cholinergic nerve containing tissue from the rat anococcygeus muscle. Br J Pharmacol. 1991 Oct;104(2):289–291. doi: 10.1111/j.1476-5381.1991.tb12422.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Moncada S., Palmer R. M., Higgs E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991 Jun;43(2):109–142. [PubMed] [Google Scholar]
  130. Moore P. K., al-Swayeh O. A., Chong N. W., Evans R. A., Gibson A. L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro. Br J Pharmacol. 1990 Feb;99(2):408–412. doi: 10.1111/j.1476-5381.1990.tb14717.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  131. Muirhead E. E. The medullipin system of blood pressure control. Am J Hypertens. 1991 Oct;4(10 Pt 2):556S–568S. doi: 10.1093/ajh/4.10.556s. [DOI] [PubMed] [Google Scholar]
  132. Myall O. T., Allen S. L., McLean W. G. The effect of acrylamide on the induction of ornithine decarboxylase in the dorsal root ganglion of the rat. Brain Res. 1990 Jul 23;523(2):295–297. doi: 10.1016/0006-8993(90)91500-g. [DOI] [PubMed] [Google Scholar]
  133. Nees S., Herzog V., Becker B. F., Böck M., Des Rosiers Ch, Gerlach E. The coronary endothelium: a highly active metabolic barrier for adenosine. Basic Res Cardiol. 1985 Sep-Oct;80(5):515–529. doi: 10.1007/BF01907915. [DOI] [PubMed] [Google Scholar]
  134. Nicholson C. D., Challiss R. A., Shahid M. Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. Trends Pharmacol Sci. 1991 Jan;12(1):19–27. doi: 10.1016/0165-6147(91)90484-a. [DOI] [PubMed] [Google Scholar]
  135. Nilsson G. E., Tottmar O. Biogenic aldehydes in brain: on their preparation and reactions with rat brain tissue. J Neurochem. 1987 May;48(5):1566–1572. doi: 10.1111/j.1471-4159.1987.tb05702.x. [DOI] [PubMed] [Google Scholar]
  136. Obeid L. M., Linardic C. M., Karolak L. A., Hannun Y. A. Programmed cell death induced by ceramide. Science. 1993 Mar 19;259(5102):1769–1771. doi: 10.1126/science.8456305. [DOI] [PubMed] [Google Scholar]
  137. Olsson R. A., Pearson J. D. Cardiovascular purinoceptors. Physiol Rev. 1990 Jul;70(3):761–845. doi: 10.1152/physrev.1990.70.3.761. [DOI] [PubMed] [Google Scholar]
  138. Oshita M., Iwanaga Y., Hashimoto S., Morikawa K., Muramatsu I. Pharmacological studies on the selectivity of HV-723, a new alpha-1 adrenoceptor antagonist. Jpn J Pharmacol. 1988 Jul;47(3):229–235. doi: 10.1254/jjp.47.229. [DOI] [PubMed] [Google Scholar]
  139. Packer M., Carver J. R., Rodeheffer R. J., Ivanhoe R. J., DiBianco R., Zeldis S. M., Hendrix G. H., Bommer W. J., Elkayam U., Kukin M. L. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med. 1991 Nov 21;325(21):1468–1475. doi: 10.1056/NEJM199111213252103. [DOI] [PubMed] [Google Scholar]
  140. Parsons A. A., Whalley E. T., Feniuk W., Connor H. E., Humphrey P. P. 5-HT1-like receptors mediate 5-hydroxytryptamine-induced contraction of human isolated basilar artery. Br J Pharmacol. 1989 Feb;96(2):434–440. doi: 10.1111/j.1476-5381.1989.tb11835.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Paton W. D., Vizi E. S. The inhibitory action of noradrenaline and adrenaline on acetylcholine output by guinea-pig ileum longitudinal muscle strip. Br J Pharmacol. 1969 Jan;35(1):10–28. doi: 10.1111/j.1476-5381.1969.tb07964.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  142. Payne A. N., Jackson W. P., Salmon J. A., Nicholls A., Yeadon M., Garland L. G. Hydroxamic acids and hydroxyureas as novel, selective 5-lipoxygenase inhibitors for possible use in asthma. Agents Actions Suppl. 1991;34:189–199. [PubMed] [Google Scholar]
  143. Penn R. D., Paice J. A., Kroin J. S. Octreotide: a potent new non-opiate analgesic for intrathecal infusion. Pain. 1992 Apr;49(1):13–19. doi: 10.1016/0304-3959(92)90182-B. [DOI] [PubMed] [Google Scholar]
  144. Pentel P. R., Keyler D. E., Gilbertson D. G., Ruth G., Pond S. M. Pharmacokinetics and toxicity of high doses of antibody Fab fragments in rats. Drug Metab Dispos. 1988 Jan-Feb;16(1):141–145. [PubMed] [Google Scholar]
  145. Peterson H. D., Burt G. B., Jr The role of steroids in prevention of circumferential capsular scarring in augmentation mammaplasty. Plast Reconstr Surg. 1974 Jul;54(1):28–30. doi: 10.1097/00006534-197407000-00003. [DOI] [PubMed] [Google Scholar]
  146. Prichard B. N., Smith C. C., Sen S., Betteridge D. J. Hypertension and insulin resistance. J Cardiovasc Pharmacol. 1992;20 (Suppl 11):S77–S84. [PubMed] [Google Scholar]
  147. Rees D. D., Cellek S., Palmer R. M., Moncada S. Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock. Biochem Biophys Res Commun. 1990 Dec 14;173(2):541–547. doi: 10.1016/s0006-291x(05)80068-3. [DOI] [PubMed] [Google Scholar]
  148. Rees S. A., Curtis M. J. Selective IK blockade as an antiarrhythmic mechanism: effects of UK66,914 on ischaemia and reperfusion arrhythmias in rat and rabbit hearts. Br J Pharmacol. 1993 Jan;108(1):139–145. doi: 10.1111/j.1476-5381.1993.tb13453.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  149. Reneman R. S., van der Starre P. J. Serotonin and acute cardiovascular disorders. Cardiovasc Drugs Ther. 1990 Jan;4 (Suppl 1):19–25. doi: 10.1007/BF00053422. [DOI] [PubMed] [Google Scholar]
  150. Richter-Levin G., Segal M. Spatial performance is severely impaired in rats with combined reduction of serotonergic and cholinergic transmission. Brain Res. 1989 Jan 16;477(1-2):404–407. doi: 10.1016/0006-8993(89)91437-6. [DOI] [PubMed] [Google Scholar]
  151. Ritz M. C., Lamb R. J., Goldberg S. R., Kuhar M. J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science. 1987 Sep 4;237(4819):1219–1223. doi: 10.1126/science.2820058. [DOI] [PubMed] [Google Scholar]
  152. Rodgers R. J., Cole J. C. Anxiety enhancement in the murine elevated plus maze by immediate prior exposure to social stressors. Physiol Behav. 1993 Feb;53(2):383–388. doi: 10.1016/0031-9384(93)90222-2. [DOI] [PubMed] [Google Scholar]
  153. Ruffolo R. R., Jr, Nichols A. J., Stadel J. M., Hieble J. P. Structure and function of alpha-adrenoceptors. Pharmacol Rev. 1991 Dec;43(4):475–505. [PubMed] [Google Scholar]
  154. Saffrey M. J., Hassall C. J., Hoyle C. H., Belai A., Moss J., Schmidt H. H., Förstermann U., Murad F., Burnstock G. Colocalization of nitric oxide synthase and NADPH-diaphorase in cultured myenteric neurones. Neuroreport. 1992 Apr;3(4):333–336. doi: 10.1097/00001756-199204000-00011. [DOI] [PubMed] [Google Scholar]
  155. Sakurai T., Yanagisawa M., Masaki T. Molecular characterization of endothelin receptors. Trends Pharmacol Sci. 1992 Mar;13(3):103–108. doi: 10.1016/0165-6147(92)90038-8. [DOI] [PubMed] [Google Scholar]
  156. Salter M., Knowles R. G., Moncada S. Widespread tissue distribution, species distribution and changes in activity of Ca(2+)-dependent and Ca(2+)-independent nitric oxide synthases. FEBS Lett. 1991 Oct 7;291(1):145–149. doi: 10.1016/0014-5793(91)81123-p. [DOI] [PubMed] [Google Scholar]
  157. Salter M., Knowles R. G., Moncada S. Widespread tissue distribution, species distribution and changes in activity of Ca(2+)-dependent and Ca(2+)-independent nitric oxide synthases. FEBS Lett. 1991 Oct 7;291(1):145–149. doi: 10.1016/0014-5793(91)81123-p. [DOI] [PubMed] [Google Scholar]
  158. Saltzman A. G., Morse B., Whitman M. M., Ivanshchenko Y., Jaye M., Felder S. Cloning of the human serotonin 5-HT2 and 5-HT1C receptor subtypes. Biochem Biophys Res Commun. 1991 Dec 31;181(3):1469–1478. doi: 10.1016/0006-291x(91)92105-s. [DOI] [PubMed] [Google Scholar]
  159. Sanguinetti M. C., Jurkiewicz N. K. Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol. 1990 Jul;96(1):195–215. doi: 10.1085/jgp.96.1.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  160. Schoeffter P., Hoyer D. 5-Hydroxytryptamine (5-HT)-induced endothelium-dependent relaxation of pig coronary arteries is mediated by 5-HT receptors similar to the 5-HT1D receptor subtype. J Pharmacol Exp Ther. 1990 Jan;252(1):387–395. [PubMed] [Google Scholar]
  161. Schoeffter P., Hoyer D. How selective is GR 43175? Interactions with functional 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors. Naunyn Schmiedebergs Arch Pharmacol. 1989 Jul;340(1):135–138. doi: 10.1007/BF00169219. [DOI] [PubMed] [Google Scholar]
  162. Seibold J. R., Molony R. R., Turkevich D., Ruddy M. C., Kostis J. B. Acute hemodynamic effects of ketanserin in pulmonary hypertension secondary to systemic sclerosis. J Rheumatol. 1987 Jun;14(3):519–524. [PubMed] [Google Scholar]
  163. Senior J., Marshall K., Sangha R., Baxter G. S., Clayton J. K. In vitro characterization of prostanoid EP-receptors in the non-pregnant human myometrium. Br J Pharmacol. 1991 Mar;102(3):747–753. doi: 10.1111/j.1476-5381.1991.tb12244.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  164. Sethia K. K., Brading A. F., Smith J. C. An animal model of non-obstructive bladder instability. J Urol. 1990 Jun;143(6):1243–1246. doi: 10.1016/s0022-5347(17)40246-1. [DOI] [PubMed] [Google Scholar]
  165. Shahid M., van Amsterdam R. G., de Boer J., ten Berge R. E., Nicholson C. D., Zaagsma J. The presence of five cyclic nucleotide phosphodiesterase isoenzyme activities in bovine tracheal smooth muscle and the functional effects of selective inhibitors. Br J Pharmacol. 1991 Oct;104(2):471–477. doi: 10.1111/j.1476-5381.1991.tb12453.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  166. Shanks R. G. The clinical pharmacology of alinidine and its side-effects. Eur Heart J. 1987 Dec;8 (Suppl 50):83–90. doi: 10.1093/eurheartj/8.suppl_l.83. [DOI] [PubMed] [Google Scholar]
  167. Smiałowski A. Inhibition of low calcium induced epileptiform discharges in the hippocampus by dopamine D1 receptor agonist, SKF 38393. Brain Res. 1990 Sep 24;528(1):148–150. doi: 10.1016/0006-8993(90)90208-s. [DOI] [PubMed] [Google Scholar]
  168. Sokoloff P., Giros B., Martres M. P., Bouthenet M. L., Schwartz J. C. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature. 1990 Sep 13;347(6289):146–151. doi: 10.1038/347146a0. [DOI] [PubMed] [Google Scholar]
  169. Somogyi P., Eshhar N., Teichberg V. I., Roberts J. D. Subcellular localization of a putative kainate receptor in Bergmann glial cells using a monoclonal antibody in the chick and fish cerebellar cortex. Neuroscience. 1990;35(1):9–30. doi: 10.1016/0306-4522(90)90116-l. [DOI] [PubMed] [Google Scholar]
  170. Steinberg M. I., Molloy B. B. Clofilum--a new antifibrillatory agent that selectively increases cellular refractoriness. Life Sci. 1979 Oct 15;25(16):1397–1406. doi: 10.1016/0024-3205(79)90417-x. [DOI] [PubMed] [Google Scholar]
  171. Stine S. M., Yang H. Y., Costa E. Evidence for ascending and descending intraspinal as well as primary sensory somatostatin projections in the rat spinal cord. J Neurochem. 1982 Apr;38(4):1144–1150. doi: 10.1111/j.1471-4159.1982.tb05361.x. [DOI] [PubMed] [Google Scholar]
  172. Supavilai P., Karobath M. The interaction of [3H]PY 108-068 and of [3H]PN 200-110 with calcium channel binding sites in rat brain. J Neural Transm. 1984;60(3-4):149–167. doi: 10.1007/BF01249091. [DOI] [PubMed] [Google Scholar]
  173. Suppes T., Kriegstein A. R., Prince D. A. The influence of dopamine on epileptiform burst activity in hippocampal pyramidal neurons. Brain Res. 1985 Feb 11;326(2):273–280. doi: 10.1016/0006-8993(85)90036-8. [DOI] [PubMed] [Google Scholar]
  174. Tanner F. C., Noll G., Boulanger C. M., Lüscher T. F. Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries. Role of scavenger receptor and endothelium-derived nitric oxide. Circulation. 1991 Jun;83(6):2012–2020. doi: 10.1161/01.cir.83.6.2012. [DOI] [PubMed] [Google Scholar]
  175. Templeton A. G., Macmillan J., McGrath J. C., Storey N. D., Wilson V. G. Evidence for prazosin-resistant, rauwolscine-sensitive alpha-adrenoceptors mediating contractions in the isolated vascular bed of the rat tail. Br J Pharmacol. 1989 Jun;97(2):563–571. doi: 10.1111/j.1476-5381.1989.tb11986.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  176. Thoenen H. The changing scene of neurotrophic factors. Trends Neurosci. 1991 May;14(5):165–170. doi: 10.1016/0166-2236(91)90097-e. [DOI] [PubMed] [Google Scholar]
  177. Thyrum P. T. Inotropic stimuli and systolic transmembrane calcium flow in depolarized guinea-pig atria. J Pharmacol Exp Ther. 1974 Jan;188(1):166–179. [PubMed] [Google Scholar]
  178. Timmermans P. B., Wong P. C., Chiu A. T., Herblin W. F. Nonpeptide angiotensin II receptor antagonists. Trends Pharmacol Sci. 1991 Feb;12(2):55–62. doi: 10.1016/0165-6147(91)90498-h. [DOI] [PubMed] [Google Scholar]
  179. Timsina M. P., Hewick D. S. Digoxin-specific Fab fragments impair renal function in the rabbit. J Pharm Pharmacol. 1992 Oct;44(10):867–869. doi: 10.1111/j.2042-7158.1992.tb03223.x. [DOI] [PubMed] [Google Scholar]
  180. Tomlinson D. R. The pharmacology of diabetic neuropathy. Diabetes Metab Rev. 1992 Apr;8(1):67–84. doi: 10.1002/dmr.5610080107. [DOI] [PubMed] [Google Scholar]
  181. Torphy T. J., Stadel J. M., Burman M., Cieslinski L. B., McLaughlin M. M., White J. R., Livi G. P. Coexpression of human cAMP-specific phosphodiesterase activity and high affinity rolipram binding in yeast. J Biol Chem. 1992 Jan 25;267(3):1798–1804. [PubMed] [Google Scholar]
  182. Turlapaty P. D., Carrier O., Jr Influence of magnesium on calcium-induced responses of atrial and vascular muscle. J Pharmacol Exp Ther. 1973 Oct;187(1):86–98. [PubMed] [Google Scholar]
  183. Verbeuren T. J., Jordaens F. H., Zonnekeyn L. L., Van Hove C. E., Coene M. C., Herman A. G. Effect of hypercholesterolemia on vascular reactivity in the rabbit. I. Endothelium-dependent and endothelium-independent contractions and relaxations in isolated arteries of control and hypercholesterolemic rabbits. Circ Res. 1986 Apr;58(4):552–564. doi: 10.1161/01.res.58.4.552. [DOI] [PubMed] [Google Scholar]
  184. Wang Q., Altermatt H. J., Ris H. B., Reynolds B. E., Stewart J. C., Bonnett R., Lim C. K. Determination of 5,10,15,20-tetra-(m-hydroxyphenyl)chlorin in tissues by high performance liquid chromatography. Biomed Chromatogr. 1993 May-Jun;7(3):155–157. doi: 10.1002/bmc.1130070311. [DOI] [PubMed] [Google Scholar]
  185. Wang Q., Ris H. B., Altermatt H. J., Reynolds B., Stewart J. C., Bonnett R., Lim C. K. Determination of 5,10,15,20-tetra-(m-hydroxyphenyl)chlorin in human plasma by high performance liquid chromatography. Biomed Chromatogr. 1993 Jan-Feb;7(1):45–47. doi: 10.1002/bmc.1130070112. [DOI] [PubMed] [Google Scholar]
  186. Weiss S. J. Tissue destruction by neutrophils. N Engl J Med. 1989 Feb 9;320(6):365–376. doi: 10.1056/NEJM198902093200606. [DOI] [PubMed] [Google Scholar]
  187. Whittington M. A., Dolin S. J., Patch T. L., Siarey R. J., Butterworth A. R., Little H. J. Chronic dihydropyridine treatment can reverse the behavioural consequences of and prevent adaptations to, chronic ethanol treatment. Br J Pharmacol. 1991 Jul;103(3):1669–1676. doi: 10.1111/j.1476-5381.1991.tb09845.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  188. Wiedow O., Schröder J. M., Gregory H., Young J. A., Christophers E. Elafin: an elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence. J Biol Chem. 1990 Sep 5;265(25):14791–14795. [PubMed] [Google Scholar]
  189. Willner P., McGuirk J., Phillips G., Muscat R. Behavioural analysis of the anorectic effects of fluoxetine and fenfluramine. Psychopharmacology (Berl) 1990;102(2):273–277. doi: 10.1007/BF02245933. [DOI] [PubMed] [Google Scholar]
  190. Wolff A. A., Levi R. Histamine and cardiac arrhythmias. Circ Res. 1986 Jan;58(1):1–16. doi: 10.1161/01.res.58.1.1. [DOI] [PubMed] [Google Scholar]
  191. Wong D. T., Threlkeld P. G., Robertson D. W. Affinities of fluoxetine, its enantiomers, and other inhibitors of serotonin uptake for subtypes of serotonin receptors. Neuropsychopharmacology. 1991 Aug;5(1):43–47. [PubMed] [Google Scholar]
  192. Wong E. H., Bonhaus D. W., Wu I., Stefanich E., Eglen R. M. Labelling of 5-hydroxytryptamine3 receptors with a novel 5-HT3 receptor ligand, [3H]RS-42358-197. J Neurochem. 1993 Mar;60(3):921–930. doi: 10.1111/j.1471-4159.1993.tb03238.x. [DOI] [PubMed] [Google Scholar]
  193. Wood P. L., Nair N. P., Lal S., Etienne P. Buspirone: a potential atypical neuroleptic. Life Sci. 1983 Jul 18;33(3):269–273. doi: 10.1016/0024-3205(83)90386-7. [DOI] [PubMed] [Google Scholar]
  194. Yaksh T. L., Wilson P. R. Spinal serotonin terminal system mediates antinociception. J Pharmacol Exp Ther. 1979 Mar;208(3):446–453. [PubMed] [Google Scholar]
  195. Yamamura M., Kinoshita K., Nakagawa H., Ishida R. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog (IV): Effects on experimental memory impairment in mice and rats. Jpn J Pharmacol. 1991 Feb;55(2):241–253. doi: 10.1254/jjp.55.241. [DOI] [PubMed] [Google Scholar]
  196. Yarchoan R., Perno C. F., Thomas R. V., Klecker R. W., Allain J. P., Wills R. J., McAtee N., Fischl M. A., Dubinsky R., McNeely M. C. Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT). Lancet. 1988 Jan 16;1(8577):76–81. doi: 10.1016/s0140-6736(88)90283-8. [DOI] [PubMed] [Google Scholar]
  197. Zhou Q. Y., Li C., Olah M. E., Johnson R. A., Stiles G. L., Civelli O. Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor. Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7432–7436. doi: 10.1073/pnas.89.16.7432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  198. Ziegra C. J., Oswald R. E., Bass A. H. [3H]kainate localization in goldfish brain: receptor autoradiography and membrane binding. Brain Res. 1990 Sep 17;527(2):308–317. doi: 10.1016/0006-8993(90)91151-6. [DOI] [PubMed] [Google Scholar]
  199. al-Tajir G., Chandler C. J., Starr B. S., Starr M. S. Opposite effects of stimulation of D1 and D2 dopamine receptors on the expression of motor seizures in mouse and rat. Neuropharmacology. 1990 Jul;29(7):657–661. doi: 10.1016/0028-3908(90)90027-o. [DOI] [PubMed] [Google Scholar]
  200. de Nucci G., Thomas R., D'Orleans-Juste P., Antunes E., Walder C., Warner T. D., Vane J. R. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci U S A. 1988 Dec;85(24):9797–9800. doi: 10.1073/pnas.85.24.9797. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES